Marsha Wills-karp

Biography

Dr. Marsha Wills-Karp is currently affiliated to Johns Hopkins Bloomberg School of Public Health, United States of America, continuing research in the specialized scientific area of Environmental Health and Engineering. Honors and Awards Chair, NIAID ZRG1 IMM-S (90)S Study Section, 2016 Chair, NIH AITRC Study Section, 2011-2015 Chair, Special Emphasis Review NIAID Panel, 2015 Kleinerman Distinguished Lecture in Pulmonary Pathobiology, 2015 Intramural NHLBI Review Committee, 2014 Delta Omega Honor Society for Public Health, 2014 Scientific Board, Trudeau Institute, 2012-2016 Deputy Editor, Mucosal Immunology, 2012-present Distinguished Lectureship, Center for Immunology & Microbial Defense Disease, Albany Medical College, 2012 Rebecca Buckely Lectureship, American Academy of Allergy and Immunology, 2012 Marsha Wills-Karp Immunobiology Student Award established at CCHMC, 2012 Member of Clinical Immunology Committee of AAI, 2011-2014 Elected Member American Society of Pediatrics, 2010-present Keystone Advisory Council Member, 2010 Permanent Member NIH AITRC Study Section, 2009-2011 Executive Leadership for Academic Medicine (ELAM) Fellow, 2007-2008 FDA, Allergenic Products Advisory Committee, 2005-2016 Distinguished Immunology Professor Award, NIAID, 2005 Distinguished Lectureship, Japan, 2005 Member of Finance Committee, American Association of Immunology, 2004-2006 Permanent Member, NIH LCMI Study Section, 2000-2004 Distinguished Alumni Award, Southwest Texas State University, 2002 John Salvaggio Memorial Lectureship, 2001 Faculty of 1000, 2000-2005 Faculty Development Award, Johns Hopkins University, 1994 Wellcome Trust Review Committee, 1998-2000, 2005, 2007 NIH Post-doctoral Training Grant, 1987-1989 First Award, National Heart, Lung and Blood Institute, 1989 Achievement and Leadership Award, Southwest Texas State University, 1981, 1982 Academic Excellence, 1980, 1981, 1982 Beta Beta Beta Biological Honor Society, 1979-1982 CONSULTANT Apellis (2015-present) Janssen Pharmaceuticals (2013-2015) Isis Pharmaceuticals, Inc. (2011-present) F. Hoffman-La Roche Ltd (2011-2012) Johnson & Johnson Pharmaceutical R&D (2011-2012) Genentech (2010-2012) Omeros Corporation (2010-2011) Merck (2007-2012) Abbott (2006-2007) Amgen (2005-2008) Centocor (2003-2006) Abgenix, Inc. (2003-2006) Merck Frosst (2002-2004) Dynavax Pharmaceuticals (1999-2004) Genetics Institute (1998-2000) Millennium (1997) Department of Energy, Beryllium Lung Disease (1998) Roche Bioscience (1997-1998) PROFESSIONAL EXPERIENCE 1987-1988 Post-doctoral Fellowship, Yale University 1988-1989 Post-doctoral Fellowship, Johns Hopkins University 1989-1990 Research Associate, Johns Hopkins University, Baltimore, Maryland 1990-1996 Assistant Professor, Johns Hopkins University, Baltimore, Maryland 1996-2000 Associate Professor, Johns Hopkins University, Baltimore, Maryland 2000-2012 Tenured Professor of Pediatrics, Director, Division of Immunobiology, Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio 2003-2010 Founder and Director, Immunobiology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, Ohio 2007-2012 Director of Center for Immunological Research, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio 2008-2011 Associate Dean for Basic Sciences, University of Cincinnati College of Medicine, Cincinnati, Ohio 2010-2012 Rieveschl Professor of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio 2012-present Chair, Department of Environmental Health Sciences, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland

Research Interest

Asthma Allergy Immunology Pulmonary Disease Environmental Health Air Pollution Microbiome Early life determinants of immune disease